²é¿´: 717  |  »Ø¸´: 7
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

rkrl001

ľ³æ (ÕýʽдÊÖ)

[½»Á÷] ¡¾½»Á÷/ÇóÖú¡¿¹ØÓÚMAPKµ°°×¼¤Ã¸µÄ»îÐԲⶨ

¸÷λͬÈÊ´ó¼ÒºÃ£º
      ÎÒ²éÔÄÁËºÜ¶à¹ØÓÚÖ²ÎïMAPKµ°°×¼¤Ã¸µÄ»îÐԲⶨ·½Ê½£¬µ«ÊÇ£¬¾ø´ó²¿·Ö¶¼ÊÇÀûÓÃÍ¬Î»ËØµÄ·½·¨£¬ÎÒÏëÎÊһϣ¬´ó¼ÒÓÐûÓÐʲôºÃµÄÒâ¼û»òÕ߲ο¼·½·¨¡£·Ç³£ÆÈÇÐÆÚ´ýÄãÃǵİïÖú¡£²»Ê¤¸Ð¼¤¡£¸Ã¼¤Ã¸ÓÖÃû£ºÖ²Îï´Ù·ÖÁÑËØ»î»¯µ°°×¼¤Ã¸¡£
  ×£´ó¼ÒÉíÌ彡¿µ£¬ÍòÊÂÈçÒâ¡£

[ Last edited by amisking on 2009-12-22 at 21:18 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

rkrl001

ľ³æ (ÕýʽдÊÖ)

£¬Ã»ÓÐ×ö¹ýµÄǰ±²Âð£¿
2Â¥2009-03-03 08:18:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

youren2008

ľ³æ (ÖøÃûдÊÖ)

ÄãÏÖÔÚ×öMAPKÁËÂð/

ÄãÏÖÔÚ×öMAPKÁËÂð/ÏëºÍÄãÌÖÂÛQQ37674130
3Â¥2009-04-10 16:35:21
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

rkrl001

ľ³æ (ÕýʽдÊÖ)

»Ø¸´£ºyouren2008

»¹Ã»×öÄØ£¬ºÇºÇ£¬²»ÏëÓÃÍ¬Î»ËØ×ö£¬¿ÉÊÇÏÖÔÚ»¹Ã»ÓÐÕÒµ½¸üºÃµÄ·½·¨¡£Äã¶¼×öÄÄЩÄÚÈݰ¡£¿½»Á÷Ò»ÏÂ
4Â¥2009-04-26 10:08:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

rkrl001

ľ³æ (ÕýʽдÊÖ)

¶¥ÆðÀ´°É£¡Ï£ÍûÓÐ֪֮ʿӻԾÁôÑÔ¡£·Ç³£¸Ðл¡£
5Â¥2009-12-20 09:17:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

runxiaoli

ľ³æ (ÕýʽдÊÖ)

¡ï ¡ï ¡ï
amisking(½ð±Ò+3,VIP+0): 12-22 21:17
ÎÒËùÖªµÄMAPK»îÐÔ¼¤Ã¸µÄ²â¶¨·½Ê½£¬Ò²ÊÇÖ»ÓÐÍ¬Î»ËØ²â¶¨·½·¨¡£
»¹ÓÐëϸ¹ÜµçÓ¾·¨£¬²»ÖªµÀÏÖÔÚÓÐûÓÐÒѾ­³ÉÊìµÄ²½Öè¡£
ÕâÊÇĿǰʵÑéÊÒ½öÓеĿÉÒÔ²Ù×÷µÄ·½Ê½¡£
ËäÈ»Í¬Î»ËØÐ§¹ûºÃ£¬µ«ÊÇÓзøÉ䣬¼´Ê¹×¢ÒâÁËÒ²²»ÄÜÍêÈ«±ÜÃâ¡£
ËùÒÔºÜÆÚ´ý´ó¼ÒµÄÓ»Ô¾·¢ÑÔ¡£°ï¶¥ÁË¡£
6Â¥2009-12-20 09:20:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÐÂÈËС«h

ľ³æ (ÕýʽдÊÖ)

Äã¿´¿´¹ØÓÚWESTEN BLOTTING
²»ÖªµÀÄܲ»Äܲâ»îÐÔ¡£Ò²ÐíÎÒϹ½²ÄØ
7Â¥2009-12-22 21:02:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

qingfengwu

½ð³æ (СÓÐÃûÆø)

¡ï ¡ï ¡ï
rkrl001(½ð±Ò+3,VIP+0):ºÜÓÐÆô·¢£¬Ð»Ð»Ö¸µã£¡ 12-23 19:46
MAPK activity assay
²»ÖªµÀÄãÊÇÒª×öÄÄÖÖMAPK£¬ ERK1/2, p38, JNKÕ⼸ÖÖÖ®ÖеÄÄÄÒ»ÖÖ£¿

Intracellular Kinases
Protein kinases transfer phosphate groups from ATP to serine, threonine, or tyrosine residues on protein peptide substrates, directly affecting the activity and function of the target. Radiolabel studies suggest that approximately 30% of proteins in eukaryotic cells are subject to phosphorylation. Kinase activity, a crucial post-translational modification, regulates a broad range of cellular activities including the cell cycle, differentiation, metabolism, and neuronal communication. In addition, abnormal activity of Akt, ERK, JNK, PKC, PKA, p38, and other MAPK are implicated in many disease states. R&D Systems offers a range of quality products for the detection of protein phosphorylation, which include kinase activity assays, phospho-specific antibodies, ELISA, and more.

£¨1£©ERK£ºERK1/ERK2




View ERK1/ERK2 IHC images.ERK1 and ERK2 (also known as MAPK3 and MAPK1) are 44- and 42-kDa Ser/Thr kinases, respectively. They are part of the Ras-Raf-ERK signal transduction cascade often found downstream of growth factor receptor activation. ERK1 and ERK2 were initially isolated and cloned as kinases activated in response to insulin and NGF. They are expressed in most, if not all, mammalian tissues. Dual threonine and tyrosine phosphorylation activate both ERKs, at Thr202/Tyr204 for human ERK1 and Thr185/Tyr187 for human ERK2.

ERK5, also known eceptor tyrosine kinases, G protein-coupled receptors, and osmotic stress. Like ERK1 and ERK2, ERK5 contains the conserved Thr-Glu-Tyr activation motif in its activation loop. Unlike these ERKs, however, ERK5 contains a unique C-terminal domain that regulates its activation and nuclear translocation

£¨2£©p38
p38 MAP Kinase


The p38 Mitogen-activated Protein Kinases (MAPKs) are a family of four related Ser/Thr kinases activated by proinflammatory cytokines and environmental stresses. All four p38 family members, alpha, beta, gamma, and delta, are phosphorylated by MKK3 and/or MKK6 at dual Thr and Tyr positions within the phosphoacceptor sequence Thr-Gly-Tyr. Once activated, p38 phosphorylates a number of targets, including the nuclear transcription factors ATF2 and Max.

The most frequently analyzed family member, p38 alpha, also known as SAPK2a and MAPK14, was initially purified as a kinase critical to the signaling cascade linking IL-1 to MAPKAPK-2 and the small heat shock protein HSP27. Ubiquitously expressed, p38 alpha is dually phosphorylated by MKK3 and MKK6 at Thr180 and Tyr182. Once activated, p38 alpha phosphorylates a number of targets, including the cytoplasmic kinases MNK 4 and PRAK5 and the nuclear transcription factors ATF2 1 and STAT1. Several promising compounds that inhibit p38 alpha are being investigated as potential therapies for arthritic and inflammatory diseases.

(3) JNK

Members of the MAPK family, the c-Jun N-terminal kinases (JNKs) are activated by environmental stresses and inflammatory cytokines. Ten JNK isoforms are created by alternative splicing of mRNA transcripts derived from three genes: JNK1, JNK2, and JNK3. All JNKs are activated by dual phosphorylation; at T183/Y185 for JNK1 and 2, and T221/Y223 for JNK3. Activated JNKs translocate to the nucleus where they regulate the activity of several transcription factors; including the c-Jun component of AP-1 and ATF-2.

ÔÚÕâÀï»ù±¾ÉϰѼ¸ÖÖÖ÷ÒªµÄMAPKµÄµ×Îï¶¼ÁоٳöÀ´ÁË¡£ÓÃÁ×ËữµÄ¿¹ÌåÅÜwesternÀ´¼ì²âøµÄ»îÐÔÊÇÆäÖеÄÒ»ÖÖ·½·¨£»Óõ×ÎïµÄÁ×ËữЧӦÅÜwestern¿ÉÒÔ½øÒ»²½ÑéÖ¤¡£
8Â¥2009-12-23 15:50:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ rkrl001 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +6 3dfhjxgsh7 2026-02-22 9/450 2026-02-23 07:49 by w4l55oybr1
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 4/200 2026-02-23 06:46 by jsjzfl
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 8rmuugja8q 2026-02-22 6/300 2026-02-23 06:39 by w4l55oybr1
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 w89i99eaeh 2026-02-22 4/200 2026-02-23 06:36 by w4l55oybr1
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 5/250 2026-02-23 06:34 by w4l55oybr1
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 khieu8v8m0 2026-02-22 5/250 2026-02-23 06:29 by w4l55oybr1
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 8/400 2026-02-23 06:24 by w4l55oybr1
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +5 3dfhjxgsh7 2026-02-22 6/300 2026-02-23 02:04 by 5jlh3qtdvx
[½Ìʦ֮¼Ò] °æÃæ·Ñ¸Ã½»Âð +7 Æ»¹ûÔÚÄÄÀï 2026-02-22 8/400 2026-02-22 22:37 by otani
[»ù½ðÉêÇë] »ù½ðÕýÎÄ30Ò³Ö¸µÄÊDZ¨¸æÕýÎÄ»¹ÊÇÕû¸öÉêÇëÊé +5 successhe 2026-02-16 6/300 2026-02-22 21:38 by ɽÎ÷Ðü¿ÕË¿ÕÐüÎ
[»ù½ðÉêÇë] ÃæÉÏ¿ÉÒÔ³¬¹ý30Ò³°É£¿ +4 °¢À­¹±aragon 2026-02-22 4/200 2026-02-22 21:22 by ɽÎ÷Ðü¿ÕË¿ÕÐüÎ
[½Ìʦ֮¼Ò] ΪʲôÖйú´óѧ½ÌÊÚÃÇË®ÁËÄÇô¶àËùνµÄ¶¥»á¶¥¿¯£¬µ«»¹ÊÇ×ö²»³öÓîÊ÷»úÆ÷ÈË£¿ +5 »¶ÀÖËÌÒ¶Ýè 2026-02-21 5/250 2026-02-22 21:15 by ɽÎ÷Ðü¿ÕË¿ÕÐüÎ
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 usprnugpzw 2026-02-21 6/300 2026-02-22 19:48 by w89i99eaeh
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 3dfhjxgsh7 2026-02-22 4/200 2026-02-22 16:52 by khieu8v8m0
[ÕÒ¹¤×÷] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 usprnugpzw 2026-02-22 3/150 2026-02-22 16:37 by khieu8v8m0
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 usprnugpzw 2026-02-21 4/200 2026-02-22 16:27 by khieu8v8m0
[»ù½ðÉêÇë] ¡°ÈËÎÄÉç¿Æ¶øÂÛ£¬Ðí¶àѧÊõÑо¿»¹Ã»ÓдﵽÃñ¹úʱÆÚµÄˮƽ¡± +4 ËÕ¶«ÆÂ¶þÊÀ 2026-02-18 5/250 2026-02-22 16:07 by liangep1573
[»ù½ðÉêÇë] ʲôÊÇÈËÒ»Éú×îÖØÒªµÄ£¿ +4 ˲ϢÓîÖæ 2026-02-21 4/200 2026-02-22 11:44 by huagongfeihu
[»ù½ðÉêÇë] ½ñÄê´ºÍíÓм¸¸ö½ÚÄ¿ºÜ²»´í£¬µãÔÞ£¡ +11 ˲ϢÓîÖæ 2026-02-16 12/600 2026-02-21 21:14 by lq493392203
[»ù½ðÉêÇë] ÌåÖÆÄÚ³¤±²ËµÌåÖÆÄÚ¾ø´ó²¿·ÖÒ»±²×ÓÔڵײ㣬ÈçͬÄãÃÇÒ»Ñù´ó²¿·ÖÆÕͨ½ÌʦæÇÒÊÕÈëµÍ +9 ˲ϢÓîÖæ 2026-02-20 12/600 2026-02-21 10:39 by »¶ÀÖËÌÒ¶Ýè
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û